Leelyn Smith, LLC Abbott Laboratories Transaction History

Leelyn Smith, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 31, 2021	SELL	$105.79 - $124.53 $9,626 - $11,332	-91 Reduced 11.29%	715 $83,000
Q4 2020 Jan 15, 2021	BUY	$105.0 - $114.42 $9,555 - $10,412	91 Added 12.73%	806 $88,000
Q3 2020 Nov 05, 2020	SELL	$91.64 - $111.29 $8,339 - $10,127	-91 Reduced 11.29%	715 $78,000
Q2 2020 Aug 06, 2020	BUY	$76.57 - $98.0 $6,967 - $8,918	91 Added 12.73%	806 $74,000
Q1 2020 May 06, 2020	SELL	$62.82 - $91.86 $879 - $1,286	-14 Reduced 1.92%	715 $56,000
Q4 2019 Feb 06, 2020	BUY	$78.51 - $87.4 $57,233 - $63,714	729 New	729 $63,000

3,208

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $224B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Leelyn Smith, LLC, based on Form 13F filings with the SEC.

Stay updated on Leelyn Smith, LLC with notifications on news.